# Pulmokine, Inc.

Canonical: https://abierto.us/vendors/pulmokine-inc-cjavxcpzuum9

- UEI: CJAVXCPZUUM9
- CAGE: 4XMX0
- Location: Slingerlands, NY
- Awards in window: 1 (1 transactions), $0 obligated, June 27, 2024 to June 27, 2024

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541712 Professional, Scientific, and Technical Services: $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- HHSN268201400013C (definitive contract): $0, National Institutes of Health Nhlbi. Vascular Interventions/Innovations and Therapeutic Advances (Vita): Ind Enabling Studies for a Novel Inhaled PDGF Receptor Inhibitor to Treat Pah. https://www.usaspending.gov/award/CONT_AWD_HHSN268201400013C_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/pulmokine-inc-cjavxcpzuum9.